• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠CD26抗原(二肽基肽酶IV)在大鼠淋巴细胞亚群上的表达。

Expression of the rat CD26 antigen (dipeptidyl peptidase IV) on subpopulations of rat lymphocytes.

作者信息

Gorrell M D, Wickson J, McCaughan G W

机构信息

A.W. Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, Australia.

出版信息

Cell Immunol. 1991 Apr 15;134(1):205-15. doi: 10.1016/0008-8749(91)90343-a.

DOI:10.1016/0008-8749(91)90343-a
PMID:1672835
Abstract

The T cell activation antigen CD26 has been recently identified as the cell surface ectopeptidase dipeptidyl peptidase IV (DPP-IV). DPP-IV is found on many cell types, including lymphocytes, epithelial cells, and certain endothelial cells. The MRC OX61 monoclonal antibody (MAb) which specifically recognises rat DPP-IV was used to examine the expression of CD26/DPP-IV on rat lymphocytes. The molecular nature of the antigen was examined by immunoprecipitation from thymocytes, splenocytes, and hepatocytes. Analysis by one- and two-dimensional gel electrophoresis indicated that the native form of CD26 includes a 220-kDa homodimer. On tissue sections MRC OX61 MAb stained nearly all thymocytes and in the spleen and lymph nodes predominantly stained the T cell areas. However, in immunofluorescence experiments OX61 stained 80 to 87% of lymph node cells and 78 to 85% of spleen cells. Furthermore, two-colour immunofluorescence analysis of the CD4+, CD8+, and Ig+ lymphocyte subsets indicated that only 2 to 5% of each of these subsets lacked OX61 staining. Spleen cells and thymocytes of both CD4+ and CD8+ subsets stained much more intensely with OX61 after these cells were stimulated with phytohemagglutinin. These findings indicate that rat CD26 antigen expression is not confined to the T cell population as has been suggested, but also occurs on B cells, and is increased on T cells following their activation.

摘要

T细胞活化抗原CD26最近被鉴定为细胞表面外肽酶二肽基肽酶IV(DPP-IV)。DPP-IV存在于许多细胞类型中,包括淋巴细胞、上皮细胞和某些内皮细胞。使用特异性识别大鼠DPP-IV的MRC OX61单克隆抗体(MAb)来检测大鼠淋巴细胞上CD26/DPP-IV的表达。通过从胸腺细胞、脾细胞和肝细胞中进行免疫沉淀来检测抗原的分子性质。一维和二维凝胶电泳分析表明,CD26的天然形式包括一个220 kDa的同二聚体。在组织切片上,MRC OX61 MAb几乎对所有胸腺细胞进行了染色,在脾脏和淋巴结中主要对T细胞区域进行了染色。然而,在免疫荧光实验中,OX61对80%至87%的淋巴结细胞和78%至85%的脾细胞进行了染色。此外,对CD4+、CD8+和Ig+淋巴细胞亚群的双色免疫荧光分析表明,这些亚群中每个亚群只有2%至5%缺乏OX61染色。在用植物血凝素刺激这些细胞后,CD4+和CD8+亚群的脾细胞和胸腺细胞用OX61染色更强烈。这些发现表明,大鼠CD26抗原的表达并不像所认为的那样局限于T细胞群体,在B细胞上也有表达,并且在T细胞活化后表达增加。

相似文献

1
Expression of the rat CD26 antigen (dipeptidyl peptidase IV) on subpopulations of rat lymphocytes.大鼠CD26抗原(二肽基肽酶IV)在大鼠淋巴细胞亚群上的表达。
Cell Immunol. 1991 Apr 15;134(1):205-15. doi: 10.1016/0008-8749(91)90343-a.
2
Binding of adenosine deaminase to the lymphocyte surface via CD26.腺苷脱氨酶通过CD26与淋巴细胞表面结合。
Eur J Immunol. 1994 Mar;24(3):566-70. doi: 10.1002/eji.1830240311.
3
Evidence that thymocyte-activating molecule is mouse CD26 (dipeptidyl peptidase IV).
J Immunol. 1991 Jul 15;147(2):447-54.
4
Dipeptidyl-peptidase IV-beta--further characterization and comparison to dipeptidyl-peptidase IV activity of CD26.二肽基肽酶IV-β——进一步的特性鉴定及与CD26二肽基肽酶IV活性的比较
Eur J Biochem. 1998 Sep 1;256(2):369-78. doi: 10.1046/j.1432-1327.1998.2560369.x.
5
CD26 antigen is a surface dipeptidyl peptidase IV (DPPIV) as characterized by monoclonal antibodies clone TII-19-4-7 and 4EL1C7.CD26抗原是一种表面二肽基肽酶IV(DPPIV),由单克隆抗体克隆TII-19-4-7和4EL1C7所鉴定。
Scand J Immunol. 1990 Apr;31(4):429-35. doi: 10.1111/j.1365-3083.1990.tb02789.x.
6
Dipeptidyl peptidase IV (CD26) activity in human alloreactive T cell subsets varies with the stage of differentiation and activation status.人同种异体反应性T细胞亚群中的二肽基肽酶IV(CD26)活性随分化阶段和激活状态而变化。
Transpl Immunol. 1997 Jun;5(2):152-61. doi: 10.1016/s0966-3274(97)80056-1.
7
Antibody binding profile of purified and cell-bound CD26. Designation of BT5/9 and TA5.9 to the CD26 cluster.纯化的和细胞结合的CD26的抗体结合谱。BT5/9和TA5.9在CD26簇中的指定。
Immunobiology. 1993 Jun;188(1-2):145-58. doi: 10.1016/S0171-2985(11)80494-8.
8
Multicolor cytoenzymatic evaluation of dipeptidyl peptidase IV (CD26) function in normal and neoplastic human T-lymphocyte populations.正常和肿瘤性人类T淋巴细胞群体中二肽基肽酶IV(CD26)功能的多色细胞酶学评估
Clin Diagn Lab Immunol. 1998 May;5(3):362-8. doi: 10.1128/CDLI.5.3.362-368.1998.
9
Is CD26/dipeptidyl peptidase IV a really important molecule in T cell activation of a certain rat strain?CD26/二肽基肽酶IV在某一大鼠品系的T细胞活化中真的是一个重要分子吗?
Immunobiology. 1995 Nov;194(4-5):429-42. doi: 10.1016/S0171-2985(11)80109-9.
10
Binding of the T cell activation monoclonal antibody Ta1 to dipeptidyl peptidase IV.
J Leukoc Biol. 1990 Oct;48(4):291-6. doi: 10.1002/jlb.48.4.291.

引用本文的文献

1
Insights into the Roles of GLP-1, DPP-4, and SGLT2 at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology.深入了解胰高血糖素样肽-1、二肽基肽酶-4和钠-葡萄糖协同转运蛋白2在心血管、肾脏和代谢病理生理学交叉点的作用
Cells. 2025 Mar 6;14(5):387. doi: 10.3390/cells14050387.
2
Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review of Structure-Activity Relationship Studies.二肽基肽酶-4抑制剂:结构-活性关系研究的系统综述
Iran J Pharm Res. 2024 Oct 29;23(1):e151581. doi: 10.5812/ijpr-151581. eCollection 2024 Jan-Dec.
3
Host polymorphisms and COVID-19 infection.
宿主基因多态性与新型冠状病毒肺炎感染
Adv Clin Chem. 2022;107:41-77. doi: 10.1016/bs.acc.2021.07.002. Epub 2021 Aug 23.
4
Emerging Role of Dipeptidyl Peptidase-4 in Autoimmune Disease.二肽基肽酶-4 在自身免疫性疾病中的新作用。
Front Immunol. 2022 Mar 4;13:830863. doi: 10.3389/fimmu.2022.830863. eCollection 2022.
5
Spared Nerve Injury Causes Sexually Dimorphic Mechanical Allodynia and Differential Gene Expression in Spinal Cords and Dorsal Root Ganglia in Rats. spared nerve injury 导致大鼠脊髓和背根神经节中具有性二态性的机械性痛觉过敏和差异基因表达。
Mol Neurobiol. 2021 Oct;58(10):5396-5419. doi: 10.1007/s12035-021-02447-1. Epub 2021 Jul 30.
6
Dipeptidylpeptidase-4 levels and DPP4 gene polymorphisms in patients with COVID-19. Association with disease and with severity.COVID-19 患者的二肽基肽酶-4 水平和 DPP4 基因多态性。与疾病和严重程度的关系。
Life Sci. 2021 Jul 1;276:119410. doi: 10.1016/j.lfs.2021.119410. Epub 2021 Mar 24.
7
DPP-4 Inhibitors as Potential Candidates for Antihypertensive Therapy: Improving Vascular Inflammation and Assisting the Action of Traditional Antihypertensive Drugs.DPP-4 抑制剂作为抗高血压治疗的潜在候选药物:改善血管炎症并辅助传统抗高血压药物的作用。
Front Immunol. 2019 May 9;10:1050. doi: 10.3389/fimmu.2019.01050. eCollection 2019.
8
Glial cell type-specific changes in spinal dipeptidyl peptidase 4 expression and effects of its inhibitors in inflammatory and neuropatic pain.脊髓二肽基肽酶 4 表达的神经胶质细胞类型特异性变化及其抑制剂在炎性和神经性疼痛中的作用。
Sci Rep. 2018 Feb 22;8(1):3490. doi: 10.1038/s41598-018-21799-8.
9
DPP4 Inhibitors Can Be a Drug of Choice for Type 3 Diabetes: A Mini Review.DPP4 抑制剂可作为 3 型糖尿病的首选药物:小型综述。
Am J Alzheimers Dis Other Demen. 2017 Nov;32(7):444-451. doi: 10.1177/1533317517722005. Epub 2017 Jul 27.
10
Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.切入正题:关于CD26/二肽基肽酶4(DPP4)在免疫系统中相互关系的综述
Clin Exp Immunol. 2016 Jul;185(1):1-21. doi: 10.1111/cei.12781. Epub 2016 May 13.